Maviret (glecaprevir/pibrentasvir)

pCPA File Number: 21011
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Hepatitis C
Sponsor/Manufacturer:
AbbVie Corporation
CDA-AMC Project Number:
SR0523-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: